Biological reagent compositions with improved sensitivity to the
concentration of blood glucose in patient samples for use in measuring
systems and methods. The reagent compositions comprise a glucose
oxidoreductase enzyme, a flavin nucleoside coenzyme and a mediator
formulation. The mediator formulation comprises at least one
electroactive organic molecule and at least one coordination complex.